Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas

Journal of Hepatology
Michael BläkerAndreas De Weerth

Abstract

Somatostatin analogues inhibit cell proliferation by stimulation of distinct somatostatin receptor (SSTR) subtypes. In recent years, these compounds have been introduced into the therapy of advanced hepatocellular carcinoma (HCC). The efficacy of this treatment is under debate due to the controversial results of clinical trials. Despite the widespread clinical use of somatostatin analogues in HCC, little is known about the expression of each of the five SSTRs in these tumors. We analyzed the expression of SSTR subtypes in 56 HCCs by immunohistochemistry using subtype-specific antibodies. Six of the samples were also investigated by RT-PCR using subtype-specific oligonucleotide primers. HCCs display differential, individual expression patterns as well as variable expression levels for SSTRs. The overall expression rate of SSTR1, SSTR2, SSTR3, SSTR4, and SSTR5 is 46, 41, 64, 0, and 75%, respectively. No significant correlation was observed between SSTR expression and tumor stage, differentiation, histological tumor type, or underlying liver disease. Individual patterns and levels of SSTR expression might determine the response to treatment with somatostatin analogues in HCC. Selective treatment of these tumors based on the analys...Continue Reading

References

Jun 1, 1993·The Journal of Clinical Endocrinology and Metabolism·D J KwekkeboomE P Krenning
Jan 25, 1996·The New England Journal of Medicine·S W LambertsL J Hofland
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Dec 26, 2001·European Journal of Endocrinology·Michael BlakerTammo von Schrenck
Jan 29, 2002·Gynecologic Oncology·Solveig SchulzWolfgang Weise
Mar 27, 2002·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Rosa TeijeiroVictor M Arce
Apr 6, 2002·Digestive Diseases·G Treiber
May 1, 2002·European Journal of Endocrinology·S W J LambertsL J Hofland
Jun 18, 2002·Oncology Reports·Demetrios N SamonakisElias Kouroumalis
Jun 20, 2002·Clinical Nuclear Medicine·Ian RabinowitzFa-Chyi Lee
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Man-Fung YuenBenjamin Chun-Yu Wong
Nov 15, 2002·Trends in Endocrinology and Metabolism : TEM·Steven W J LambertsLeo J Hofland

❮ Previous
Next ❯

Citations

Jul 13, 2006·Journal of Cancer Research and Clinical Oncology·G TreiberP Malfertheiner
Dec 13, 2005·Journal of Clinical Gastroenterology·Dimitrios N SamonakisElias A Kouroumalis
Nov 6, 2009·Journal of Experimental & Clinical Cancer Research : CR·Maximilian Schöniger-HekeleChristian Müller
Mar 12, 2013·International Journal of Peptides·Federica BarbieriTullio Florio
Oct 23, 2014·Endocrine-related Cancer·Omar Abdel-RahmanRichard A Hubner
Jul 1, 2010·Expert Opinion on Drug Discovery·Oded OvadiaHorst Kessler
Jan 17, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Xue ZhangHongqi Zhang
Jul 23, 2013·Frontiers in Neuroendocrinology·Marily Theodoropoulou, Günter K Stalla
Apr 24, 2007·Seminars in Oncology·Philippe RougierJulien Taieb
Jan 25, 2005·Journal of Hepatology·Malika LasferFlorence J Reyl-Desmars
Oct 31, 2009·Chemico-biological Interactions·Ivan BorbathYves Horsmans
Jan 5, 2011·Journal of Biomedicine & Biotechnology·Susan J Turrell, Adrian Whitehouse
Apr 3, 2014·TheScientificWorldJournal·Martina SolliniAnnibale Versari
Jun 9, 2009·Journal of Experimental & Clinical Cancer Research : CR·Céline KerrosStéphane Allouche
Jan 24, 2015·Investigational New Drugs·Hanna K SanoffBert H O'Neil
Jul 4, 2016·Critical Reviews in Oncology/hematology·Angela LamarcaJorge Barriuso
Mar 24, 2018·Cancer Cell International·K LohiteshSudeshna Mukherjee
May 17, 2007·British Journal of Cancer·F FarinatiV D Corleto
Jan 24, 2019·Clinical Nuclear Medicine·Elena TabacchiValentina Ambrosini
Oct 2, 2019·International Journal of Molecular Sciences·Hendrik Reynaert, Isabelle Colle
Sep 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Romain EychenneNicolas Lepareur
Jun 27, 2019·BioMed Research International·Rui-Sheng ZhouYing Tang
Aug 20, 2019·Seminars in Cancer Biology·Muhammed H ElnaggarSamy Zaky
Oct 5, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J TaiebP Rougier
Nov 18, 2021·Expert Opinion on Investigational Drugs·Zachary J BrownTimothy M Pawlik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.